4978.T
ReproCELL Incorporated
グロース · 化学 · 素材・化学 · JP
JPY 146.00
−0.68%Year over year
Reported trailing growth
- Revenue
- -7.3%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -9.6%
- EBITDA
- —
- EPS
- -78.8%
Three-year CAGR
- Revenue
- +10.1%
- EBITDA
- +78.1%
- EBIT
- +68.2%
- Net income
- +432.3%
- EPS
- +400.0%
- Free cash flow
- +55.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026